These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 9816013

  • 1. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.
    Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS.
    Clin Cancer Res; 1995 May; 1(5):539-44. PubMed ID: 9816013
    [Abstract] [Full Text] [Related]

  • 2. Genetic analysis of eight breast-ovarian cancer families with suspected BRCA1 mutations.
    Couch FJ, Garber J, Kiousis S, Calzone K, Hauser ER, Merajver SD, Frank TS, Boehnke M, Chamberlain JS, Collins FS.
    J Natl Cancer Inst Monogr; 1995 May; (17):9-14. PubMed ID: 8573462
    [Abstract] [Full Text] [Related]

  • 3. German family study on hereditary breast and/or ovarian cancer: germline mutation analysis of the BRCA1 gene.
    Hamann U, Brauch H, Garvin AM, Bastert G, Scott RJ.
    Genes Chromosomes Cancer; 1997 Feb; 18(2):126-32. PubMed ID: 9115962
    [Abstract] [Full Text] [Related]

  • 4. [Germ-line mutation of BRCA1 in patients with breast and/or ovarian cancer in high risk families in Northern France].
    Peyrat JP, Vennin P, Hornez L, Bonneterre J.
    Bull Cancer; 1997 Jan; 84(1):41-6. PubMed ID: 9180858
    [Abstract] [Full Text] [Related]

  • 5. CGH analysis of familial non-BRCA1/BRCA2 breast tumors and mutation screening of a candidate locus on chromosome 17q11.2-12.
    Maguire P, Holmberg K, Kost-Alimova M, Imreh S, Skoog L, Lindblom A.
    Int J Mol Med; 2005 Jul; 16(1):135-41. PubMed ID: 15942690
    [Abstract] [Full Text] [Related]

  • 6. BRCA1 mutations in familial ovarian cancer.
    Lallas TA, Buekers TE, Buller RE.
    Mol Genet Metab; 1999 Aug; 67(4):357-63. PubMed ID: 10444347
    [Abstract] [Full Text] [Related]

  • 7. Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds.
    Neuhausen SL, Marshall CJ.
    Cancer Res; 1994 Dec 01; 54(23):6069-72. PubMed ID: 7954448
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Loss of heterozygosity in normal breast epithelial tissue and benign breast lesions in BRCA1/2 carriers with breast cancer.
    Cavalli LR, Singh B, Isaacs C, Dickson RB, Haddad BR.
    Cancer Genet Cytogenet; 2004 Feb 01; 149(1):38-43. PubMed ID: 15104281
    [Abstract] [Full Text] [Related]

  • 11. Germline mutations of the BRCA1 and BRCA2 genes in a breast and ovarian cancer patient.
    Randall TC, Bell KA, Rebane BA, Rubin SC, Boyd J.
    Gynecol Oncol; 1998 Sep 01; 70(3):432-4. PubMed ID: 9790802
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q.
    Stratton MR, Ford D, Neuhasen S, Seal S, Wooster R, Friedman LS, King MC, Egilsson V, Devilee P, McManus R.
    Nat Genet; 1994 May 01; 7(1):103-7. PubMed ID: 8075631
    [Abstract] [Full Text] [Related]

  • 14. [Germline mutation of BRCA1 gene in Polish families with strong aggregation of breast and/or ovarian cancer based on coding sequence analysis using the SSCP method].
    Byrski T.
    Ann Acad Med Stetin; 2003 May 01; 49():27-43. PubMed ID: 15552838
    [Abstract] [Full Text] [Related]

  • 15. Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer families.
    Giannini G, Capalbo C, Ristori E, Ricevuto E, Sidoni T, Buffone A, Cortesi E, Marchetti P, Scambia G, Tomao S, Rinaldi C, Zani M, Ferraro S, Frati L, Screpanti I, Gulino A.
    Breast Cancer Res Treat; 2006 Nov 01; 100(1):83-91. PubMed ID: 16847550
    [Abstract] [Full Text] [Related]

  • 16. Mutation analysis of the THRA1 gene in breast cancer: deletion/fusion of the gene to a novel sequence on 17q in the BT474 cell line.
    Futreal PA, Cochran C, Marks JR, Iglehart JD, Zimmerman W, Barrett JC, Wiseman RW.
    Cancer Res; 1994 Apr 01; 54(7):1791-4. PubMed ID: 7511052
    [Abstract] [Full Text] [Related]

  • 17. BRCA1 and BRCA2 mutation status and tumor characteristics in male breast cancer: a population-based study in Italy.
    Ottini L, Masala G, D'Amico C, Mancini B, Saieva C, Aceto G, Gestri D, Vezzosi V, Falchetti M, De Marco M, Paglierani M, Cama A, Bianchi S, Mariani-Costantini R, Palli D.
    Cancer Res; 2003 Jan 15; 63(2):342-7. PubMed ID: 12543786
    [Abstract] [Full Text] [Related]

  • 18. Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.
    Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.
    Hum Mutat; 2005 Mar 15; 25(3):319. PubMed ID: 15712267
    [Abstract] [Full Text] [Related]

  • 19. Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families.
    Xu CF, Chambers JA, Nicolai H, Brown MA, Hujeirat Y, Mohammed S, Hodgson S, Kelsell DP, Spurr NK, Bishop DT, Solomon E.
    Genes Chromosomes Cancer; 1997 Feb 15; 18(2):102-10. PubMed ID: 9115959
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.